Skip to main content

and
  1. Article

    Open Access

    Monitoring immunE DysregulAtion foLLowing Immune checkpOint-inhibitioN (MEDALLION): protocol for an observational cancer immunotherapy cohort study

    Checkpoint inhibitors (CPIs) are widely used in cancer treatment, with transformative impacts on survival. They nonetheless carry a significant risk of toxicity in the form of immune-related adverse events (Ir...

    Abigail Gault, Linda Hogarth, Kristian C Williams, Alastair Greystoke in BMC Cancer (2024)